# Troy City Council approves special-use permit for community > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/troy-city-council-approves-special-use-permit-for-community-solar-farm/ > **Published:** 2026-09-03T13:06:22-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T16:55:36-04:00 > **Clinical Summary:** Content mismatch detected: headline and clinical summary do not align. Recommend full article review. --- ✦ New CED Clinical Relevance #35 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyIndustrySafetyResearchHempPediatricsMental Health Clinical Summary # Clinical Summary This article appears to document regulatory approval for a community solar facility in Troy, though the headline and content summary are misaligned. However, the embedded reference indicates that patients with primary mitochondrial oxidative stress (PMOS) and sickle cell disease have become newly eligible for medical cannabis treatment as of September 2, 2026. This regulatory change expands access to cannabis as a therapeutic option for two distinct patient populations: those with mitochondrial dysfunction and those with severe hemolytic anemia and chronic pain. Clinicians treating patients with these conditions should become familiar with the evidence base for cannabis efficacy in managing the pain, inflammation, and energy metabolism issues associated with these diseases, as well as local regulations governing prescription and dispensing. Understanding the timing and scope of this eligibility expansion is important for informed patient counseling about potential treatment options and their integration with standard care. The practical takeaway for clinicians is to review updated state or local medical cannabis guidelines to determine whether cannabis therapy is appropriate for individual PMOS or sickle cell patients in their practice and what monitoring protocols should accompany any such treatment. Clinical Perspective βš•οΈ While this article primarily addresses solar energy infrastructure and public health policy, the mention of cannabis eligibility expansion for sickle cell disease patients warrants clinical attention. Sickle cell disease causes severe, recurrent pain crises that significantly impact quality of life, and emerging evidence suggests cannabinoids may offer adjunctive symptom management through analgesic and anti-inflammatory mechanisms. However, clinicians should remain cautious given the limited high-quality evidence specific to sickle cell populations, potential drug interactions with hydroxyurea and other standard therapies, and variability in cannabis formulations and potency across jurisdictions. Individual patient factors including age, comorbidities, substance use history, and psychological considerations should guide any discussion about cannabis as part of a comprehensive pain management strategy. As access expands, hematologists and primary care providers should establish clear protocols for discussing evidence, monitoring outcomes, and coordinating care with patients who choose to πŸ’¬ Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan β†’](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion β†’](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Troy%20City%20Council%20approves%20special-use%20permit%20for%20community%20solar%20farm%20%40drcaplan&url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D75768)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D75768)[πŸ¦… Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Troy%20City%20Council%20approves%20special-use%20permit%20for%20community%20solar%20farm%20via%20%40drcaplan.bsky.social%20https%3A%2F%2Fcedclinic.com%2F%3Fp%3D75768)[πŸ“· Follow on Instagram](https://www.instagram.com/drbenjamincaplan)[πŸ“ Read more on Substack](https://doctorapprovedcannabis.substack.com/)[πŸ”” Subscribe via RSS](https://cedclinic.com/feed/) Related Articles - [CED Digest: 436 Items β€” March 14, 2026](https://cedclinic.com/cannabis-compounds-fatty-liver-disease-2026/) - [CED Digest: 405 Items β€” March 12, 2026](https://cedclinic.com/alabama-medical-cannabis-sales-2026-spring-launch/) πŸ“° Source: [https://www.timestribunenews.com/2026/09/03/troy-city-council-approves-special-use-permit-for-community-solar-farm/](https://www.timestribunenews.com/2026/09/03/troy-city-council-approves-special-use-permit-for-community-solar-farm/) Further Reading CED Clinic Blog[Why Cannabis Works](https://cedclinic.com/why-cannabis-works/) Evidence Watch[Cannabis and Heart Health](https://cedclinic.com/cannabis-cardiovascular-health-study/) CED Clinic Blog[Cannabis for Sleep](https://cedclinic.com/cannabis-for-sleep/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) #### πŸ“„ Printable 1-Page Physician Patient Guide Download or print Dr. Benjamin Caplan’s official clinical reference guide to share with your healthcare team. ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR Β§ 164.514(b)) and criteria for secondary research exemption under 45 CFR Β§ 46.104(d)(4).